BCIQ Profiles

Company Profile Report
DIST_0430_sciimmunol.abe2933 online now

Blocking NLRP3 deubiquitination for inflammasome-associated disease

Apr 30, 2021 | 7:27 PM GMT

DISEASE CATEGORY: Autoimmune; hepatic; infectious; inflammation

INDICATION: Multiple sclerosis (MS); liver disease; sepsis;

Read the full 252 word article

How to gain access

Continue reading with a
two-week free trial.